BLAIV (INFUSION)INJECTABLE
Approved
Jan 2026
Lifecycle
Launch
Competitive Pressure
30/100
Mechanism of Action
membrane-bound IL-6 receptors (sIL-6R and mIL-6R), and have been shown to inhibit IL-6-mediated signaling through these receptors. IL-6 is a pleiotropic pro-inflammatory cytokine produced by a variety of cell types including T- and B-cells, lymphocytes, monocytes and fibroblasts. IL-6 has been…
Indications (13)
more Disease-Modifying Anti-Rheumatic Drugs (DMARDs)giant cell arteritis (GCA) in adult patientsactive polyarticular juvenile idiopathic arthritis in patients 2 years of ageolderactive systemic juvenile idiopathic arthritis in patients 2 years of agechimeric antigen receptor (CAR) T cell-induced severelife-threatening cytokine release syndrome in adultscoronavirus disease 2019 (COVID-19) in hospitalized adult patientsrequire supplemental oxygennon- invasiveinvasive mechanical ventilationextracorporeal membrane oxygenation (ECMO)Rheumatoid Arthritis
Company
Celltrion
Korea - Incheon
External Resources